Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Pernot

Showing results (51-60 of 101) with videos related to

Pageof 11
Sort By:
British Journal of Cancer|January 30, 2022
Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO studySonia Zaibet, Vincent Hautefeuille, Edouard Auclin, et al.
Cancers|June 26, 2025
Inhibition of PCSK9 Attenuates Liver Endothelial Cell Activation Induced by Colorectal Cancer Stem Cells During Liver MetastasisAnder Martin, Daniela Gerovska, Marcos J Arauzo-Bravo, et al.
Scientific Reports|February 26, 2021
Episomal HPV16 responsible for aggressive and deadly metastatic anal squamous cell carcinoma evidenced in peripheral bloodHélène Péré, Raphael Vernet, Simon Pernot, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 7, 2013
Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohortSimon Pernot, Emmanuel Mitry, Emmanuelle Samalin, et al.
Clinical Colorectal Cancer|September 14, 2020
Aflibercept in Combination With FOLFIRI as First-line Chemotherapy in Patients With Metastatic Colorectal Cancer (mCRC): A Phase II Study (FFCD 1302)Alexandra Lapeyre-Prost, Simon Pernot, Julie Sigrand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2021
Regorafenib-Avelumab Combination in Patients with Microsatellite Stable Colorectal Cancer (REGOMUNE): A Single-arm, Open-label, Phase II TrialSophie Cousin, Coralie Cantarel, Jean-Philippe Guegan, et al.
Clinics and Research in Hepatology and Gastroenterology|October 15, 2019
Three fluoropyrimidine-based regimens in routine clinical practice after nab-paclitaxel plus gemcitabine for metastatic pancreatic cancer: An AGEO multicenter studyAnne-Laure Pointet, David Tougeron, Simon Pernot, et al.
British Journal of Cancer|June 9, 2020
Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 studySimon Pernot, Olivier Pellerin, Pascal Artru, et al.
International Journal of Molecular Sciences|October 29, 2025
Plasma Protein Biomarkers to Detect Early Gastric Preneoplasia and Cancer: A Prospective StudyQuentin Giai Gianetto, Valérie Michel, Thibaut Douché, et al.
The Oncologist|July 21, 2019
Inclusion of Older Patients with Cancer in Clinical Trials: The SAGE Prospective Multicenter Cohort SurveyFlorence Canouï-Poitrine, Astrid Lièvre, Florent Dayde, et al.
Pageof 11

Showing results (51-60 of 101) with videos related to

Sort By:
Pageof 11
British Journal of Cancer|January 30, 2022
Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO studySonia Zaibet, Vincent Hautefeuille, Edouard Auclin, et al.
Cancers|June 26, 2025
Inhibition of PCSK9 Attenuates Liver Endothelial Cell Activation Induced by Colorectal Cancer Stem Cells During Liver MetastasisAnder Martin, Daniela Gerovska, Marcos J Arauzo-Bravo, et al.
Scientific Reports|February 26, 2021
Episomal HPV16 responsible for aggressive and deadly metastatic anal squamous cell carcinoma evidenced in peripheral bloodHélène Péré, Raphael Vernet, Simon Pernot, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 7, 2013
Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohortSimon Pernot, Emmanuel Mitry, Emmanuelle Samalin, et al.
Clinical Colorectal Cancer|September 14, 2020
Aflibercept in Combination With FOLFIRI as First-line Chemotherapy in Patients With Metastatic Colorectal Cancer (mCRC): A Phase II Study (FFCD 1302)Alexandra Lapeyre-Prost, Simon Pernot, Julie Sigrand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2021
Regorafenib-Avelumab Combination in Patients with Microsatellite Stable Colorectal Cancer (REGOMUNE): A Single-arm, Open-label, Phase II TrialSophie Cousin, Coralie Cantarel, Jean-Philippe Guegan, et al.
Clinics and Research in Hepatology and Gastroenterology|October 15, 2019
Three fluoropyrimidine-based regimens in routine clinical practice after nab-paclitaxel plus gemcitabine for metastatic pancreatic cancer: An AGEO multicenter studyAnne-Laure Pointet, David Tougeron, Simon Pernot, et al.
British Journal of Cancer|June 9, 2020
Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 studySimon Pernot, Olivier Pellerin, Pascal Artru, et al.
International Journal of Molecular Sciences|October 29, 2025
Plasma Protein Biomarkers to Detect Early Gastric Preneoplasia and Cancer: A Prospective StudyQuentin Giai Gianetto, Valérie Michel, Thibaut Douché, et al.
The Oncologist|July 21, 2019
Inclusion of Older Patients with Cancer in Clinical Trials: The SAGE Prospective Multicenter Cohort SurveyFlorence Canouï-Poitrine, Astrid Lièvre, Florent Dayde, et al.
Pageof 11